Advances in diagnostic markers of chronic traumatic encephalopathy

doi:10.3877/cma.j.issn.2095-9141.2022.05.009

Abstract

Abstract:

Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with repetitive head trauma, which characterized by abnormal accumulation of a large number of phosphorylated Tau protein in the brain. Severe cognitive and behavior disfunction, and even dementia or suicide may occur in later stages of CTE, which seriously impacts the life quality of patients. At present, clinical diagnosis of CTE is very difficult due to a lack of objective diagnostic biomarkers, and diagnosis can only be made by autopsy, putting a heavy burden on family and society. The biomarkers related to CTE diagnosis have important clinical value in assessing the degree of injury, early diagnosis, and treatment protocol decision-making, etc.. Therefore, this review was conducted by analyzing and summaring the cerebrospinal fluid blood and other related biomarkers associated with CTE diagnosis, in order to provide reference for early diagnosis and clinical treatment.

Key words: Chronic traumatic encephalopathy, Diagnostic biomarkers, Phosphorylated Tau protein, Cerebrospinal fluid

Zhuangzhuang Bai, Dongbo Li, Qian Yang. Advances in diagnostic markers of chronic traumatic encephalopathy[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2022, 08(05): 302-306.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsjcswkdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9141.2022.05.009

https://zhsjcswkdzzz.cma-cmc.com.cn/EN/Y2022/V08/I05/302

Figures/Tables 1

References 48

[1]	Mondello S, Schmid K, Berger RP, et al. The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage[J]. Med Res Rev, 2014, 34(3): 503-531.
[2]	Binney ZO, Bachynski KE. Estimating the prevalence at death of CTE neuropathology among professional football players[J]. Neurology, 2019, 92(1): 43-45.
[3]	McKee AC, Abdolmohammadi B, Stein TD. The neuropathology of chronic traumatic encephalopathy[J]. Handb Clin Neurol, 2018, 158: 297-307.
[4]	Mez J, Stern RA, McKee AC. Chronic traumatic encephalopathy[J]. Semin Neurol, 2020, 40(4): 351-352.
[5]	Changa AR, Vietrogoski RA, Carmel PW. Dr Harrison Martland and the history of punch drunk syndrome[J]. Brain, 2018, 141(1): 318-321.
[6]	Critchley M. Medical aspects of boxing, particularly from a neurological standpoint[J]. Br Med J, 1957: 1(5015): 357-362.
[7]	Stein TD, Alvarez VE, McKee AC. Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel[J]. Alzheimers Res Ther, 2014, 6(1): 4.
[8]	Corsellis JA, Bruton CJ, Freeman-Browne D. The aftermath of boxing[J]. Psychol Med, 1973, 3(3): 270-303.
[9]	陈伟成，蔡凯宇，陈君涵, 等. 规律运动对慢性创伤性脑病的改善效应及其机制[J]. 中华神经医学杂志, 2022, 21(3): 305-311.
[10]	McKee AC, Cairns NJ, Dickson DW, et al. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy[J]. Acta Neuropathol, 2016, 131(1): 75-86.
[11]	路旭，杨俊丽，王娜, 等. 慢性创伤性脑病研究进展[J]. 中华神经创伤外科电子杂志, 2020, 6(4): 244-247.
[12]	Muraoka S, Jedrychowski MP, Tatebe H, et al. Proteomic profiling of extracellular vesicles isolated from cerebrospinal fluid of former national football league players at risk for chronic traumatic encephalopathy[J]. Front Neurosci, 2019, 13: 1059.
[13]	Tran HT, LaFerla FM, Holtzman DM, et al. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities[J]. J Neurosci, 2011, 31(26): 9513-9525.
[14]	Rubenstein R, Chang B, Yue JK, et al. Comparing plasma phospho Tau, total Tau, and phospho Tau-total Tau ratio as acute and chronic traumatic brain injury biomarkers[J]. JAMA Neurol, 2017, 74(9): 1063-1072.
[15]	Teunissen CE, Khalil M. Neurofilaments as biomarkers in multiple sclerosis[J]. Mult Scler, 2012, 18(5): 552-556.
[16]	Shahim P, Zetterberg H, Tegner Y, et al. Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports[J]. Neurology, 2017, 88(19): 1788-1794.
[17]	Dickstein DL, De Gasperi R, Gama Sosa MA, et al. Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure[J]. Mol Psychiatry, 2021, 26(10): 5940-5954.
[18]	Zetterberg H, Blennow K. From cerebrospinal fluid to blood: the third wave of fluid biomarkers for Alzheimer's disease[J]. J Alzheimers Dis, 2018, 64(s1): S271-S279.
[19]	Tiwari S, Atluri V, Kaushik A, et al. Alzheimer's disease: pathogenesis, diagnostics, and therapeutics[J]. Int J Nanomedicine, 2019, 14: 5541-5554.
[20]	Stein TD, Montenigro PH, Alvarez VE, et al. Beta-amyloid deposition in chronic traumatic encephalopathy[J]. Acta Neuropathol, 2015, 130(1): 21-34.
[21]	Ikonomovic MD, Mi Z, Abrahamson EE. Disordered APP metabolism and neurovasculature in trauma and aging: combined risks for chronic neurodegenerative disorders[J]. Ageing Res Rev, 2017, 34: 51-63.
[22]	Sass D, Guedes VA, Smith EG, et al. Sex differences in behavioral symptoms and the levels of circulating GFAP, Tau, and NfL in patients with traumatic brain injury[J]. Front Pharmacol, 2021, 12: 746491.
[23]	Yuan W, Lu L, Rao M, et al. GFAP hyperpalmitoylation exacerbates astrogliosis and neurodegenerative pathology in PPT1-deficient mice[J]. Proc Natl Acad Sci USA, 2021, 118(13): e2022261118.
[24]	Mondello S, Jeromin A, Buki A, et al. Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury[J]. J Neurotrauma, 2012, 29(6): 1096-1104.
[25]	Kleindienst A, Ross Bullock M. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury[J]. J Neurotrauma, 2006, 23(8): 1185-200.
[26]	Esposito G, Scuderi C, Lu J, et al. S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells[J]. J Cell Mol Med, 2008, 12(3): 914-927.
[27]	Moreira GG, Cantrelle FX, Quezada A, et al. Dynamic interactions and Ca2+-binding modulate the holdase-type chaperone activity of S100B preventing tau aggregation and seeding[J]. Nat Commun, 2021, 12(1): 6292.
[28]	Grevfors N, Lindblad C, Nelson DW, et al. Delayed neurosurgical intervention in traumatic brain injury patients referred from primary hospitals is not associated with an unfavorable outcome[J]. Front Neurol, 2021, 11: 610192.
[29]	Riuzzi F, Chiappalupi S, Arcuri C, et al. S100 proteins in obesity: liaisons dangereuses[J]. Cell Mol Life Sci, 2020, 77(1): 129-147.
[30]	Ackermans NL, Varghese M, Wicinski B, et al. Unconventional animal models for traumatic brain injury and chronic traumatic encephalopathy[J]. J Neurosci Res, 2021, 99(10): 2463-2477.
[31]	Bazarian JJ, Biberthaler P, Welch RD, et al. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study[J]. Lancet Neurol, 2018, 17(9): 782-789.
[32]	Tate CM, Wang KK, Eonta S, et al. Serum brain biomarker level, neurocognitive performance, and self-reported symptom changes in soldiers repeatedly exposed to low-level blast: a breacher pilot study[J]. J Neurotrauma, 2013, 30(19): 1620-1630.
[33]	Posti JP, Hossain I, Takala RS, et al. Glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 are not specific biomarkers for mild CT-negative traumatic brain injury[J]. J Neurotrauma, 2017, Epub ahead of print.
[34]	Chung-Esaki HM, Mui G, Mlynash M, et al. The neuron specific enolase (NSE) ratio offers benefits over absolute value thresholds in post-cardiac arrest coma prognosis[J]. J Clin Neurosci, 2018, 57: 99-104.
[35]	Kulbe JR, Geddes JW. Current status of fluid biomarkers in mild traumatic brain injury[J]. Exp Neurol, 2016, 275 Pt 3(3): 334-352.
[36]	Shahim P, Tegner Y, Wilson DH, et al. Blood biomarkers for brain injury in concussed professional ice hockey players[J]. JAMA Neurol, 2014, 71(6): 684-692.
[37]	Zhao Y, Jaber V, Alexandrov PN, et al. MicroRNA-based biomarkers in alzheimer's disease (AD)[J]. Front Neurosci, 2020, 14: 585432.
[38]	Ferrante M, Conti GO. Environment and neurodegenerative diseases: an update on miRNA role[J]. Microrna, 2017, 6(3): 157-165.
[39]	Mitra B, Rau TF, Surendran N, et al. Plasma micro-RNA biomarkers for diagnosis and prognosis after traumatic brain injury: a pilot study[J]. J Clin Neurosci, 2017, 38: 37-42.
[40]	LaRocca D, Barns S, Hicks SD, et al. Comparison of serum and saliva miRNAs for identification and characterization of mTBI in adult mixed martial arts fighters[J]. PLoS One, 2019, 14(1): e0207785.
[41]	Cherry JD, Tripodis Y, Alvarez VE, et al. Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy[J]. Acta Neuropathol Commun, 2016, 4(1): 112.
[42]	Chausse B, Kakimoto PA, Kann O. Microglia and lipids: how metabolism controls brain innate immunity[J]. Semin Cell Dev Biol, 2021, 112: 137-144.
[43]	Recasens M, Almolda B, Pérez-Clausell J, et al. Chronic exposure to IL-6 induces a desensitized phenotype of the microglia[J]. J Neuroinflammation, 2021, 18(1): 31.
[44]	Hugon J, Hourregue C, Cognat E, et al. Chronic traumatic encephalopathy. Neurochirurgie[J]. 2021, 67(3): 290-294.
[45]	Wilde EA, Hunter JV, Li X, et al. Chronic effects of boxing: diffusion tensor imaging and cognitive findings[J]. J Neurotrauma, 2016, 33(7): 672-680.
[46]	Palmqvist S, Schöll M, Strandberg O, et al. Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity[J]. Nat Commun, 2017, 8(1): 1214.
[47]	Hansson O, Mormino EC. Is longitudinal tau PET ready for use in alzheimer's disease clinical trials?[J]. Brain, 2018, 141(5): 1241-1244.
[48]	Smith DH, Johnson VE, Stewart W. Chronic neuropathologies of single and repetitive TBI: substrates of dementia?[J]. Nat Rev Neurol, 2013, 9(4): 211-221.

标志物		生物功能	意义	参考文献
脑脊液标志物
	p-Tau	与轴突损伤相关	p-Tau蛋白水平与反复创伤严重程度相关，颅脑创伤后在脑脊液中升高	[12,13,14]
	NFL	存在于神经元细胞质中，是神经元细胞骨架成分	轴突损伤最具有代表性的标志物	[17,18]
	Aβ	易引起神经元损伤或死亡，导致神经退行性病变	特异性不高，与年龄相关	[19,20,21]
	GFAP	仅由星形胶质细胞表达，在细胞骨架受损后释放	脑损伤后升高，标志着神经胶质细胞增生和神经炎症，已被用作短期内神经退行性疾病进展的衡量标准	[22,23,24]
	S100β	钙结合蛋白，参与很多病理生理反应，并能预测神经系统的损伤	特异性差，其他细胞也可以分泌	[27,28,29]
血液标志物
	UCH-L1	清除神经元中错误折叠、氧化或过量的蛋白质	在慢性神经退行性疾病中广泛应用，但灵敏度低	[32,33]
	NSE	神经细胞损伤或坏死后升高	灵敏度低	[34,35]
	miRNA	调控中枢神经系统正常运行	特异性高，灵敏度高	[37,38,39,40]
其他标志物
	炎性因子	神经炎症贯穿颅脑损伤的全过程	特异性差，灵敏度低	[41,42,43]
	影像标志	正电子发射断层扫描成像	成像耗时且昂贵	[44,48]

标志物		生物功能	意义	参考文献
脑脊液标志物
	p-Tau	与轴突损伤相关	p-Tau蛋白水平与反复创伤严重程度相关，颅脑创伤后在脑脊液中升高	[12,13,14]
	NFL	存在于神经元细胞质中，是神经元细胞骨架成分	轴突损伤最具有代表性的标志物	[17,18]
	Aβ	易引起神经元损伤或死亡，导致神经退行性病变	特异性不高，与年龄相关	[19,20,21]
	GFAP	仅由星形胶质细胞表达，在细胞骨架受损后释放	脑损伤后升高，标志着神经胶质细胞增生和神经炎症，已被用作短期内神经退行性疾病进展的衡量标准	[22,23,24]
	S100β	钙结合蛋白，参与很多病理生理反应，并能预测神经系统的损伤	特异性差，其他细胞也可以分泌	[27,28,29]
血液标志物
	UCH-L1	清除神经元中错误折叠、氧化或过量的蛋白质	在慢性神经退行性疾病中广泛应用，但灵敏度低	[32,33]
	NSE	神经细胞损伤或坏死后升高	灵敏度低	[34,35]
	miRNA	调控中枢神经系统正常运行	特异性高，灵敏度高	[37,38,39,40]
其他标志物
	炎性因子	神经炎症贯穿颅脑损伤的全过程	特异性差，灵敏度低	[41,42,43]
	影像标志	正电子发射断层扫描成像	成像耗时且昂贵	[44,48]

Please choose a citation manager

Content to export